Poole Jonathan 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Feb 12, 2018
Insider Transaction Report
Form 4
Poole Jonathan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-08+217,708→ 217,708 totalExercise: $0.98Exp: 2028-02-07→ Common Stock (217,708 underlying)
Footnotes (1)
- [F1]The options granted will vest annually in 48 equal monthly installments beginning on the first monthly anniversary of the grant date. The Company's Board of Directors also approved on February 8, 2018 that, subject to stockholder approval, Jonathan Poole will receive 257,292 additional options with the same grant date, at the same exercise price and pursuant to the same vesting schedule.